Symbotic’s (SYM) Bullish Thesis Intact as TD Cowen Highlights Major Customer Acquisition, Deployment Acceleration Despite High Valuation

Symbotic Inc. (NASDAQ:SYM) is one of the best stocks for the next decade. On December 3, TD Cowen raised the firm’s price target on Symbotic to $75 from $50 and maintained a Buy rating on the shares. While the firm acknowledged that the stock’s valuation has become stretched following the earnings report, the underlying results support the core bullish thesis. The quarter showcased significant milestones, like the acquisition of a major customer in a new market and acceleration in deployment timelines.

In FY2025, Symbotic Inc. (NASDAQ:SYM) achieved a revenue increase of 26%, with FQ4 revenue rising 7.23% year-over-year to $618.46 million. However, the company also reported a net loss of $19 million in the quarter, which was a shift from the $16 million net income recorded in FQ4 2024. Still, the company’s EPS for FQ4 totaled $0.58, which exceeded guidance by $0.50.

A major milestone in FQ4 was the signing of Medline, which marked Symbotic’s official entry into the healthcare vertical. Additionally, the company is nearing completion of its first GreenBox site in Atlanta, which is a warehouse-as-a-service venture that has garnered significant customer interest. For FQ1 2026, Symbotic Inc. (NASDAQ:SYM) issued revenue guidance between $610 and $630 million, representing growth of 25% to 29%. Management indicated that revenue growth may be less pronounced in H1 2026 as the company transitions to its next-gen storage designs.

Symbotic Inc. (NASDAQ:SYM) is an automation technology company that develops technologies to enhance operating efficiencies in modern warehouses.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.